Vaccination with a neural-derived peptide plus administration of glutathione improves the performance of paraplegic rats

European Journal of Neuroscience

Volumn 26, Issue 2, 2007, Pages 403-412

  Martinon S ^a   Garcia E ^a   Flores, N ^a   Gonzalez, I ^a   Ortega, T ^a   Buenrostro, M ^a   Reyes, R ^a   Fernandez Presas, A M ^b   Guizar Sahagun G ^a   Correa, D ^c   Ibarra, A ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Compression; Glutathione mono ethyl ester; Neuroprotection; Protective autoimmunity; Reimmunization; Spinal cord injury

Indexed keywords

A91 PEPTIDE; GLUTATHIONE ETHYL ESTER; LIPID; PEPTIDE DERIVATIVE; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CLONAL ANERGY; CONTROLLED STUDY; CONVALESCENCE; DRUG INHIBITION; FEMALE; IMMUNIZATION; LIPID PEROXIDATION; MOTOR DYSFUNCTION; MYELINATED NERVE; NERVE CELL; NERVE FIBER; NONHUMAN; PARAPLEGIA; PERFORMANCE; PRIORITY JOURNAL; RAT; RUBROSPINAL TRACT; SPINAL CORD INJURY; T LYMPHOCYTE; VACCINATION;

ALGORITHMS; ANIMALS; APOPTOSIS; AXONS; CELL PROLIFERATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLUTATHIONE; IMMUNOTHERAPY; LIPID PEROXIDATION; MOVEMENT; MYELIN SHEATH; NEUROPEPTIDES; PARAPLEGIA; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; T-LYMPHOCYTES; VACCINATION;

EID: 34447625768     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05650.x     Document Type: Article

References (50)

1. Abbas, A.K. (1996) Die and let live: eliminating dangerous lymphocytes. Cell, 84, 655 657.
2. Abbas, A.K., Lohr, J., Knoechel, B. Nagabhushanam, V. (2004) T cell tolerance and autoimmunity. Autoimmun. Rev., 3, 471 475.
3. Avidan, H., Kipnis, J., Butovsky, O., Caspi, R.R. Schwartz, M. (2004) Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells. Eur. J. Immunol., 34, 3434 3445.
4. Basso, D.M., Beattie, M.S. Bresnahan, J.C. (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma, 12, 1 21.
5. Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J.A., McFarland, H.F. Martin, R. (2000) Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand 4. Nat. Med., 6, 1167 1175.
6. Buchwald, U.K., Lees, A., Steinitz, M. Pirofski, L.A. (2005) A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice. Infect. Immun., 73, 325 333.
7. Chamberlain, M.C., Sloan, A. Vrionis, F. (2005) Systematic review of the diagnosis and management of malignant extradural spine cord compression: The Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J. Clin. Oncol., 23, 7750 7751.
8. Diaz-Ruiz, A., Rios, C., Duarte, I., Correa, D., Guizar-Sahagun, G., Grijalva, I., Madrazo, I. Ibarra, A. (2000) Lipid peroxidation inhibition in spinal cord injury: cyclosporin-A vs methylprednisolone. Neuroreport, 11, 1765 1767.
9. Dobkin, B.H. Havton, L.A. (2004) Basic advances and new avenues in therapy of spinal cord injury. Annu. Rev. Med., 55, 255 282.
10. Droge, W., Schulze-Osthoff, K., Mihm, S., Galter, D., Schenk, H., Eck, H.P., Roth, S. Gmunder, H. (1994) Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J., 8, 1131 1138.
11. Dumont, R.J., Okonkwo, D.O., Verma, S., Hurlbert, R.J., Boulos, P.T., Ellegala, D.B. Dumont, A.S. (2001a) Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin. Neuropharmacol., 24, 254 264.
12. Dumont, R.J., Verma, S., Okonkwo, D.O., Hurlbert, R.J., Boulos, P.T., Ellegala, D.B. Dumont, A.S. (2001b) Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin. Neuropharmacol., 24, 265 279.
13. Fee, D., Crumbaugh, A., Jacques, T., Herdrich, B., Sewell, D., Auerbach, D.N., Piaskowski, S., Hart, M.N., Sandor, M. Fabry, Z. (2003) Activated/effector CD4+. T cells exacerbate acute damage in the central nervous system following traumatic injury. J. Neuroimmunol., 136, 54 66.
14. Gaur, A., Boehme, S.A., Chalmers, D., Crowe, P.D., Pahuja, A., Ling, N., Brocke, S., Steinman, L. Conlon, P.J. (1997) Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J. Neuroimmunol., 74, 149 158.
15. Gerndt, S.J., Rodriguez, J.L., Pawlik, J.W., Taheri, P.A., Wahl, W.L., Micheals, A.J. Papadopoulos, S.M. (1997) Consequences of high-dose steroid therapy for acute spinal cord injury. J. Trauma, 42, 279 284.
16. Gorio, A., Gokmen, N., Erbayraktar, S., Yilmaz, O., Madaschi, L., Cichetti, C., Di Giulio, A.M., Vardar, E., Cerami, A. Brines, M. (2002) Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. PNAS, 99, 9450 9455.
17. Guizar-Sahagun, G., Ibarra, A., Espitia, A., Martinez, A., Madrazo, I. Franco-Bourland, R.E. (2005) Glutathione monoethyl ester improves functional recovery, enhances neuron survival, and stabilizes spinal cord blood flow after spinal cord injury in rats. Neuroscience, 130, 639 649.
18. Hauben, E., Agranov, E., Gothilf, A., Nevo, U., Cohen, A., Smirnov, I., Steinman, L. Schwartz, M. (2001a) Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J. Clin. Invest, 108, 591 599.
19. Hauben, E., Butovsky, O., Nevo, U., Yoles, E., Moalem, G., Agranov, E., Mor, F., Leibowitz-Amit, R., Pevsner, E., Akselrod, S., Neeman, M., Cohen, I.R. Schwartz, M. (2000a) Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci., 20, 6421 6430.
20. Hauben, E., Gothilf, A., Cohen, A., Butovsky, O., Nevo, U., Smirnov, I., Yoles, E., Akselrod, S. Schwartz, M. (2003) Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J. Neurosci., 23, 8808 8819.
21. Hauben, E., Ibarra, A., Mizrahi, T., Barouch, R., Agranov, E. Schwartz, M. (2001b) Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc. Natl Acad. Sci. USA, 98, 15173 15178.
22. Hauben, E., Nevo, U., Yoles, E., Moalem, G., Agranov, E., Mor, F., Akselrod, S., Neeman, M., Cohen, I.R. Schwartz, M. (2000b) Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet, 355, 286 287.
23. Hofstetter, H.H., Sewell, D.L., Liu, F., Sandor, M., Forsthuber, T., Lehmann, P.V. Fabry, Z. (2003) Autoreactive T cells promote post-traumatic healing in the central nervous system. J. Neuroimmunol., 134, 25 34.
24. Ibarra, A., Correa, D., Willms, K., Merchant, M.T., Guizar-Sahagun, G., Grijalva, I. Madrazo, I. (2003) Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury. Brain Res., 979, 165 178.
25. Ibarra, A., Hauben, E., Butovsky, O. Schwartz, M. (2004) The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats. Eur. J. Neurosci., 19, 2984 2990.
26. Ikoev, V.N., Gorbunov, M.A., Maidaniuk, A.G., Karpovich, L.G., Kalashnikova, T.V., Bektimirov, T.A., Karpova, E.V., Nemtsov, I., Muntlieva, M.A. Kriuk, N.I. (1999) [Characteristics of reactogenic and immunogenic properties of the children's variant of the domestic vaccine, 'Gep-A-in-Vak', against hepatitis A]. Vopr. Virusol., 44, 133 136.
27. Jones, T.B., Ankeny, D.P., Guan, Z., McGaughy, V., Fisher, L.C., Basso, D.M. Popovich, P.G. (2004) Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J. Neurosci., 24, 3752 3761.
28. Khan, M. Griebel, R. (1983) Acute spinal cord injury in the rat: comparison of three experimental techniques. Can. J. Neurol. Sci., 10, 161 165.
29. Khan, M., Griebel, R., Rozdilsky, B. Politis, M. (1985) Hemorrhagic changes in experimental spinal cord injury models. Can. J. Neurol. Sci., 12, 259 262.
30. Kidd, P.M. (1997) Glutathione: systemic protectant against oxidative and free radical damage. Altern. Med. Rev., 2, 155 176.
31. Kipnis, J., Mizrahi, T., Yoles, E., Ben-Nun, A. Schwartz, M. (2002) Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol., 130, 78 85.
32. Kipnis, J., Yoles, E., Schori, H., Hauben, E., Shaked, I. Schwartz, M. (2001) Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J. Neurosci., 21, 4564 4571.
33. Klimova, R.R., Kozlov, A.I., Shingarova, L.N., Nekrasova, O.V., Boldyreva, E.F., Guseva, T.S., Parshina, O.V., Malinovskaia, V.V., Novikov, V.V. Kushch, A.A. (2004) [Effect of tumor necrosis factor DNA on immune response to DNA immunization against herpes simplex virus]. Mol. Biol. (Mosk.), 38, 333 342.
34. Lasalle, J.M. (1994) T cell anergy. FASEB J., 8, 601 608.
35. Lechler, R., Chai, J.G., Marelli-Berg, F. Lombardi, G. (2001) The contribution of T-cell anergy to peripheral T-cell tolerance. Immunology, 103, 262 269.
36. Liu, J.K., Cole, C.D., Sherr, G.T., Kestle, J.R. Walker, M.L. (2005) Noncommunicating spinal extradural arachnoid cyst causing spinal cord compression in a child. J. Neurosurg, 103, 266 269.
37. Maiorova, G.F., Akatov, A.K., Ogienko, N.M., Vorob'ev, A.A. Tsertsvadze, G.G. (1978) [Efficacy of the per os immunization and reimmunization of man with staphylococcal anatoxin]. Zh. Mikrobiol. Epidemiol. Immunobiol., 10, 32 36.
38. Mukhtar, I.A., Letts, M. Kontio, K. (2005) Spinal cord impingement by a displaced rib in scoliosis due to neurofibromatosis. Can. J. Surg., 48, 414 415.
39. Park, E., Velumian, A.A. Fehlings, M.G. (2004) The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J. Neurotrauma, 21, 754 774.
40. Popovich, P.G. Jones, T.B. (2003) Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci., 24, 13 17.
41. Potas, J.R., Zheng, Y., Moussa, C., Venn, M., Gorrie, C.A., Deng, C. Waite, P.M. (2006). Augmented locomotor recovery after spinal cord injury in the athymic nude rat. J. Neurotrauma, 23, 660 673.
42. Qian, T., Guo, X., Levi, A.D., Vanni, S., Shebert, R.T. Sipski, M.L. (2005) High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord., 43, 199 203.
43. Santoscoy, C., Rios, C., Franco-Bourland, R.E., Hong, E., Bravo, G., Rojas, G. Guizar-Sahagun, G. (2002) Lipid peroxidation by nitric oxide supplements after spinal cord injury: effect of antioxidants in rats. Neurosci. Lett., 330, 94 98.
44. Schwartz, M. Kipnis, J. (2004) A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis. Trends Pharmacol. Sci., 25, 407 412.
45. Schwartz, M., Moalem, G., Leibowitz-Amit, R. Cohen, I.R. (1999) Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci., 22, 295 299.
46. Shaked, I., Porat, Z., Gersner, R., Kipnis, J. Schwartz, M. (2004) Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system. J. Neuroimmunol., 146, 84 93.
47. Shaked, I., Tchoresh, D., Gersner, R., Meiri, G., Mordechai, S., Xiao, X., Hart, R.P. Schwartz, M. (2005) Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. J. Neurochem., 92, 997 1009.
48. Thornberry, N.A. (1994) Interleukin-1 beta converting enzyme. Meth. Enzymol., 244, 615 631.
49. Wolf, S.A., Fisher, J., Bechmann, I., Steiner, B., Kwidzinski, E. Nitsch, R. (2002) Neuroprotection by T-cells depends on their subtype and activation state. J. Neuroimmunol., 133, 72 80.
50. Yoles, E., Hauben, E., Palgi, O., Agranov, E., Gothilf, A., Cohen, A., Kuchroo, V., Cohen, I.R., Weiner, H. Schwartz, M. (2001) Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci., 21, 3740 3748.